On this page
Care priority and warning signs
Care priority
Link to Care / Initiate Prophylaxis / Schedule Testing
Red flags
- Any signs of illness (needs assessment per IMCI).
- Poor growth or development.
- Signs suggestive of HIV infection (thrush, recurrent infections etc.).
Assessment
- Ask: Has the mother had an HIV test? (Mother is HIV-positive).
- Ask: Has the child had an HIV test?
- Determine child's status based on tests and age:
- Case 1: Mother HIV+ AND child had negative DNA PCR test while breastfeeding or stopped < 6 weeks ago.
- Case 2: Mother HIV+ AND child not yet tested.
- Case 3: Mother HIV+ AND child < 18 months had positive serological (antibody) test.
- Ask: Is the child breastfeeding now?
- Ask: Is the mother on ART and child on ARV prophylaxis (if breastfeeding)?
Classification
- (Mother HIV-positive AND Negative DNA PCR test in breastfeeding child or stopped < 6 weeks ago) OR (Mother HIV-positive AND Child not yet tested) OR (Mother HIV-positive AND Positive serological test in infant < 18 months) -> HIV EXPOSED
Key features
- Child born to HIV-positive mother.
- Child's definitive HIV status is not yet confirmed negative (either untested, inconclusive test timing relative to breastfeeding, or positive antibody test <18m which reflects maternal antibodies).
- Requires co-trimoxazole prophylaxis until definitive negative status confirmed after breastfeeding cessation.
- Requires timely EID testing (DNA PCR).
- Requires specific counselling on safe infant feeding (AFASS criteria if considering stopping breastfeeding).
Management
Non-pharmacological management
- Assess feeding and provide appropriate counselling based on mother's choice and circumstances (breastfeeding vs replacement feeding - counsel on AFASS criteria Page 28 if considering stopping breastfeeding).
- Link child to ART/Mother Baby care point for follow-up, ARV prophylaxis (if breastfeeding), and EID testing.
- Monitor growth and development.
- Assess for TB (see page 9).
Pharmacological treatment
- Give Co-trimoxazole prophylaxis daily. Start at 6 weeks of age (or at first contact if older). Dose: Age 6 weeks - 6 months: 2.5ml syrup (or 1 infant tab). Age >6 months - 5 years: 5ml syrup (or 1 adult tab/2 infant tabs). Continue until HIV infection definitively excluded after cessation of breastfeeding.
- Ensure child receives appropriate ARV prophylaxis according to national PMTCT guidelines (especially if breastfeeding).
- Perform DNA PCR test to confirm HIV status at appropriate time points (e.g., 6 weeks, after breastfeeding cessation - follow national EID algorithm). If DNA PCR is positive -> Confirmed HIV Infection. If negative after breastfeeding cessation -> HIV Infection Unlikely.
- Ensure immunizations are up-to-date (follow schedule, give BCG at birth unless symptomatic).
Follow-up
- Regular follow-up at Mother-Baby care point/ART clinic for EID testing, monitoring, ARV prophylaxis refills, and continued co-trimoxazole.
- Final HIV test (usually rapid test) around 18-24 months or after breastfeeding cessation to confirm status.
Counselling points
- Explain the meaning of 'HIV Exposed' - child needs testing to know status.
- Explain the importance of daily Co-trimoxazole prophylaxis.
- Explain the importance of ARV prophylaxis for the baby if breastfeeding.
- Provide detailed counselling on safe infant feeding options (exclusive breastfeeding for first 6 months is generally recommended for exposed infants in resource-limited settings if mother is on ART; discuss stopping breastfeeding and AFASS criteria - page 28). Emphasize exclusive feeding method.
- Explain the schedule for EID testing (DNA PCR).
- Counsel on importance of mother's own health and ART adherence.
- Advise on assessing for TB.
- Advise on signs of illness requiring immediate care.
Differential diagnosis
- Confirmed HIV Infection
- HIV Infection Unlikely
Complications
- Risk of acquiring HIV infection if PMTCT is suboptimal.
- Increased risk of common childhood illnesses.
- Side effects of prophylactic medications (rare).
Prevention
- Effective PMTCT including maternal ART.
- Infant ARV prophylaxis.
- Safe infant feeding practices.
- Co-trimoxazole prophylaxis.
References
IMCI Chart Booklet - Page 8, Page 9 (TB check), Page 14 (Co-trimoxazole), Pages 25-28 (Feeding, AFASS)